| Expression pattern: |
UP |
| Associated gene: |
SLC7A11 |
| Associated microRNA: |
miR-545-3p |
| Biological function: |
Circ_0072088 acts as an oncogenic circRNA in PDAC, promoting cell viability, proliferation, migration, invasion, tumour growth and glycolysis, while inhibiting apoptosis and oxygen consumption rate. |
| Molecular mechanism: |
Circ_0072088 functions through a ceRNA mechanism by targeting miR-545-3p and thereby regulating SLC7A11 expression in PDAC. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); glycolysis (promotes); ceRNA regulation (other); other pathway/process (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Microarray; Clinical Sample Validation; Luciferase Reporter Assay; Transfection; CCK8; Annexin V/PI Flow Cytometry; Transwell Assay; In Vivo Animal Model; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
High circ_0072088 level was associated with high TNM stage and advanced TNM stage in PDAC patients. |
| Description: |
Circ_0072088/hsa_circRNA_103809 is up-regulated in PDAC tumours and cell lines and its high expression is associated with advanced TNM stage. Functionally, circ_0072088 promotes PDAC cell viability, migration, invasion, tumour growth and glycolysis while suppressing apoptosis. Mechanistically, it acts through the circ_0072088/miR-545-3p/SLC7A11 ceRNA axis. |
| Confidence score: |
0.7416 |